NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/24/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization808.22 mln
Float32.82 mln
Earnings Date08/10/2026
EPS
1.66
Decent
P / E
12.66
Fair value
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.72
Likely reliable
1-Year Forecast
22.83
Modest upside
Relative Strength
79
/ 100
Strongly outperforming
Business Description
Amphastar Pharmaceuticals is a drug maker based in Rancho Cucamonga, California, operating across the United States, China, and France since 1996. The company produces and sells a broad range of injectable, inhaled, and nasal medicines, covering both branded and generic treatments for conditions such as severe low blood sugar, asthma, opioid overdose, blood clots, and osteoporosis, among others. Amphastar also supplies raw pharmaceutical ingredients, including insulin, to support broader drug manufacturing needs.